Hong Kong & Macau have ordered pharmaceutical major GlaxoSmithKline (GSK) to recall the antibiotic Augmentin used for treating infections because it contained detectable levels of chemical additives. According to the Hong Kong health department, tests revealed GSK’s Augmentin antibiotic tablet (375mg) contained several plasticisers, including diisodecyl phthalate (DIDP) & di(2-ethylhexyl) phthalate (DEHP), raising “quality concerns”. The information was [...] Read more…
